Volta Medical

Volta Medical is a France-based startup with a mission to leverage Artificial Intelligence in revolutionizing interventional cardiac electrophysiology. The company's flagship product, the Volta AF-Xplorer, uses machine and deep learning algorithms to assist operators during cardiac ablation procedures, specifically targeting complex arrhythmias such as atrial fibrillation.

Volta AF-Xplorer's real-time analysis algorithm, trained on meticulously curated databases of annotated intra-cardiac electrograms, provides support for electrogram-based atrial fibrillation ablation. The system has received both CE marking and FDA clearance, attesting to its compliance with stringent regulatory standards.

Founded in 2016, Volta Medical has rapidly expanded its presence globally, forming strategic partnerships with leading centers in Europe and the US. The latest milestone for the company was a €36.00M Series B investment received on 05 January 2023, with funding from Lightstone Ventures, Gilde Healthcare, and Vensana Capital.

Volta Medical's commitment to user-friendly solutions and its innovative application of AI in healthcare and medical devices positions it as a compelling player in the intersection of technology and cardiology.